Moderna Common
(MRNA)
|
5.7 |
$177M |
|
460k |
384.86 |
Amgen Common
(AMGN)
|
3.9 |
$122M |
|
575k |
212.65 |
Unitedhealth Group Common
(UNH)
|
3.9 |
$120M |
|
306k |
390.74 |
Gilead Sciences Common
(GILD)
|
3.8 |
$119M |
|
1.7M |
69.85 |
Horizon Therapeutics Shares
|
3.2 |
$100M |
|
910k |
109.54 |
Regeneron Pharmaceuticals Common
(REGN)
|
2.9 |
$90M |
|
148k |
605.18 |
Thermo Fisher Scientific Common
(TMO)
|
2.7 |
$84M |
|
146k |
571.33 |
Johnson & Johnson Common
(JNJ)
|
2.7 |
$83M |
|
517k |
161.50 |
Illumina Common
(ILMN)
|
2.5 |
$79M |
|
194k |
405.61 |
Abbott Laboratories Common
(ABT)
|
2.5 |
$78M |
|
657k |
118.13 |
Medtronic Shares
(MDT)
|
2.4 |
$75M |
|
601k |
125.35 |
Biogen Common
(BIIB)
|
2.1 |
$66M |
|
234k |
282.99 |
Eli Lilly and Company Common
(LLY)
|
2.0 |
$64M |
|
275k |
231.05 |
Merck & Co Common
(MRK)
|
2.0 |
$61M |
|
816k |
75.11 |
AbbVie Common
(ABBV)
|
1.8 |
$57M |
|
524k |
107.87 |
IDEXX Laboratories Common
(IDXX)
|
1.6 |
$50M |
|
80k |
621.89 |
Vertex Pharmaceuticals Common
(VRTX)
|
1.6 |
$50M |
|
273k |
181.39 |
AstraZeneca Sponsored ADR
(AZN)
|
1.6 |
$49M |
|
813k |
60.06 |
Guardant Health Common
(GH)
|
1.6 |
$49M |
|
388k |
125.01 |
Danaher Corp. Common
(DHR)
|
1.5 |
$45M |
|
149k |
304.44 |
Cigna Corp. Common
(CI)
|
1.4 |
$44M |
|
222k |
200.16 |
Stryker Corp. Common
(SYK)
|
1.3 |
$40M |
|
151k |
263.72 |
Sarepta Therapeutics Common
(SRPT)
|
1.3 |
$39M |
|
427k |
92.48 |
Rallybio Corp. Common
(RLYB)
|
1.2 |
$38M |
|
2.3M |
16.29 |
Bristol-Myers Squibb Company Common
(BMY)
|
1.2 |
$36M |
|
612k |
59.17 |
McKesson Corp. Common
(MCK)
|
1.2 |
$36M |
|
182k |
199.38 |
Alnylam Pharmaceuticals Common
(ALNY)
|
1.2 |
$36M |
|
190k |
188.81 |
Seagen Common
|
1.1 |
$35M |
|
207k |
169.80 |
Zimmer Biomet Holdings Common
(ZBH)
|
1.0 |
$33M |
|
223k |
146.36 |
Charles River Laboratories International Common
(CRL)
|
1.0 |
$32M |
|
79k |
412.67 |
Novavax Common
(NVAX)
|
1.0 |
$31M |
|
152k |
207.31 |
Zoetis Class A
(ZTS)
|
0.9 |
$28M |
|
143k |
194.14 |
HCA Healthcare Common
(HCA)
|
0.9 |
$27M |
|
112k |
242.72 |
United Therapeutics Corp. Class B
(UTHR)
|
0.9 |
$27M |
|
145k |
184.58 |
Laboratory Corporation of America Holdings Sponsored ADR
|
0.9 |
$27M |
|
95k |
281.44 |
Icon Shares
(ICLR)
|
0.8 |
$26M |
|
99k |
262.02 |
Dexcom Common
(DXCM)
|
0.8 |
$24M |
|
43k |
546.86 |
BeiGene Sponsored ADR
|
0.7 |
$23M |
|
64k |
363.00 |
Molina Healthcare Common
(MOH)
|
0.7 |
$23M |
|
84k |
271.31 |
BioNTech SE Sponsored ADS
(BNTX)
|
0.7 |
$22M |
|
81k |
272.99 |
Edwards Lifesciences Corp. Common
(EW)
|
0.7 |
$22M |
|
195k |
113.21 |
Exact Sciences Corp. Common
(EXAS)
|
0.7 |
$22M |
|
225k |
95.45 |
Dentsply Sirona Common
(XRAY)
|
0.7 |
$21M |
|
368k |
58.05 |
Syneos Health Class A
|
0.7 |
$21M |
|
244k |
87.48 |
Humana Common
(HUM)
|
0.7 |
$21M |
|
53k |
389.14 |
Intuitive Surgical Common
(ISRG)
|
0.6 |
$20M |
|
20k |
994.15 |
Pfizer Common
(PFE)
|
0.6 |
$19M |
|
450k |
43.01 |
Catalent Common
|
0.6 |
$19M |
|
144k |
133.07 |
IQVIA Holdings Common
(IQV)
|
0.6 |
$18M |
|
77k |
239.54 |
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.6 |
$18M |
|
162k |
111.93 |
Health Care Select Sector SPDR Fund SBI Healthcare
(XLV)
|
0.5 |
$17M |
|
133k |
127.30 |
Welltower Common
(WELL)
|
0.5 |
$17M |
|
203k |
82.40 |
Caribou Biosciences Common
(CRBU)
|
0.5 |
$16M |
|
699k |
22.34 |
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.5 |
$15M |
|
114k |
130.21 |
Mirati Therapeutics Common
|
0.5 |
$15M |
|
84k |
176.91 |
Ventas Common
(VTR)
|
0.4 |
$14M |
|
248k |
55.21 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.4 |
$13M |
|
204k |
62.43 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.4 |
$13M |
|
141k |
90.19 |
Biohaven Pharmaceutical Holding Company Common
|
0.4 |
$13M |
|
91k |
138.91 |
CVS Health Corp. Common
(CVS)
|
0.4 |
$13M |
|
148k |
84.86 |
Karuna Therapeutics Common
|
0.4 |
$12M |
|
101k |
122.33 |
Intra-Cellular Therapies Common
(ITCI)
|
0.4 |
$12M |
|
324k |
37.28 |
Neurocrine Biosciences Common
(NBIX)
|
0.4 |
$12M |
|
125k |
95.91 |
I-Mab Sponsored ADS
(IMAB)
|
0.4 |
$12M |
|
163k |
72.49 |
argenx SE Sponsored ADR
(ARGX)
|
0.4 |
$12M |
|
39k |
302.01 |
Alkermes Shares
(ALKS)
|
0.4 |
$12M |
|
374k |
30.84 |
Adaptive Biotechnologies Corp. Common
(ADPT)
|
0.4 |
$12M |
|
338k |
33.99 |
Denali Therapeutics Common
(DNLI)
|
0.4 |
$11M |
|
222k |
50.45 |
Novartis Sponsored ADR
(NVS)
|
0.4 |
$11M |
|
136k |
81.78 |
Ionis Pharmaceuticals Common
(IONS)
|
0.3 |
$11M |
|
323k |
33.54 |
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.3 |
$11M |
|
68k |
159.39 |
Becton, Dickinson and Company Common
(BDX)
|
0.3 |
$11M |
|
43k |
245.83 |
Waters Corp. Common
(WAT)
|
0.3 |
$10M |
|
29k |
357.30 |
BioMarin Pharmaceutical Common
(BMRN)
|
0.3 |
$9.9M |
|
128k |
77.29 |
Owens & Minor Common
(OMI)
|
0.3 |
$9.2M |
|
295k |
31.29 |
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.3 |
$9.2M |
|
96k |
96.01 |
Omega Healthcare Investors Common
(OHI)
|
0.3 |
$9.2M |
|
306k |
29.96 |
Mettler-Toledo International Common
(MTD)
|
0.3 |
$9.2M |
|
6.7k |
1377.29 |
Physicians Realty Trust Common
|
0.3 |
$8.7M |
|
496k |
17.62 |
G1 Therapeutics Common
|
0.3 |
$8.4M |
|
624k |
13.42 |
Universal Health Services Class B
(UHS)
|
0.3 |
$8.3M |
|
60k |
138.36 |
Medical Properties Trust Common
(MPW)
|
0.3 |
$8.3M |
|
412k |
20.07 |
Boston Scientific Corp. Common
(BSX)
|
0.3 |
$8.1M |
|
186k |
43.39 |
Turning Point Therapeutics Common
|
0.3 |
$7.9M |
|
119k |
66.43 |
Intellia Therapeutics Common
(NTLA)
|
0.3 |
$7.8M |
|
58k |
134.15 |
uniQure Shares
(QURE)
|
0.2 |
$7.6M |
|
237k |
32.01 |
Sutro Biopharma Common
(STRO)
|
0.2 |
$7.6M |
|
400k |
18.89 |
Sabra Health Care REIT Common
(SBRA)
|
0.2 |
$7.5M |
|
511k |
14.72 |
Sanofi Sponsored ADR
(SNY)
|
0.2 |
$7.4M |
|
153k |
48.21 |
Koninklijke Philips NY Reg Shares
(PHG)
|
0.2 |
$7.3M |
|
165k |
44.44 |
Galera Therapeutics Common
(GRTX)
|
0.2 |
$7.3M |
|
898k |
8.10 |
Arvinas Common
(ARVN)
|
0.2 |
$7.1M |
|
86k |
82.18 |
Addus HomeCare Corp. Common
(ADUS)
|
0.2 |
$6.7M |
|
84k |
79.75 |
Apellis Pharmaceuticals Common
(APLS)
|
0.2 |
$6.5M |
|
196k |
32.96 |
Agilent Technologies Common
(A)
|
0.2 |
$6.2M |
|
40k |
157.53 |
Smith & Nephew Sponsored ADR
(SNN)
|
0.2 |
$6.2M |
|
182k |
34.34 |
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.2 |
$5.9M |
|
608k |
9.74 |
PerkinElmer Common
(RVTY)
|
0.2 |
$5.8M |
|
33k |
173.30 |
LTC Properties Common
(LTC)
|
0.2 |
$5.8M |
|
182k |
31.69 |
Amicus Therapeutics Common
(FOLD)
|
0.2 |
$5.6M |
|
587k |
9.55 |
Aurinia Pharmaceuticals Common
(AUPH)
|
0.2 |
$5.6M |
|
253k |
22.13 |
Qiagen Shares
|
0.2 |
$5.6M |
|
108k |
51.68 |
Anthem Common
(ELV)
|
0.2 |
$5.5M |
|
15k |
372.78 |
VectivBio Holding Shares
|
0.2 |
$5.4M |
|
757k |
7.10 |
Travere Therapeutics Common
(TVTX)
|
0.2 |
$5.2M |
|
213k |
24.25 |
Kura Oncology Common
(KURA)
|
0.2 |
$5.1M |
|
274k |
18.73 |
Healthpeak Properties Common
(DOC)
|
0.2 |
$5.0M |
|
150k |
33.48 |
Arena Pharmaceuticals Common
|
0.2 |
$5.0M |
|
84k |
59.55 |
Align Technology Common
(ALGN)
|
0.2 |
$5.0M |
|
7.5k |
665.37 |
Theravance Biopharma Common
(TBPH)
|
0.2 |
$4.9M |
|
656k |
7.40 |
R1 RCM Common
|
0.1 |
$4.5M |
|
202k |
22.01 |
Fate Therapeutics Common
(FATE)
|
0.1 |
$4.3M |
|
73k |
59.28 |
Verona Pharma Sponsored ADR
(VRNA)
|
0.1 |
$4.1M |
|
752k |
5.48 |
Zai Lab Adr
(ZLAB)
|
0.1 |
$4.0M |
|
38k |
105.40 |
Mereo BioPharma Group Ads
(MREO)
|
0.1 |
$3.8M |
|
1.6M |
2.42 |
ResMed Common
(RMD)
|
0.1 |
$3.7M |
|
14k |
263.58 |
Affimed Common
|
0.1 |
$3.6M |
|
586k |
6.18 |
Scholar Rock Holding Corp. Common
(SRRK)
|
0.1 |
$3.6M |
|
109k |
33.02 |
Medpace Holdings Common
(MEDP)
|
0.1 |
$3.6M |
|
19k |
189.29 |
Vir Biotechnology Common
(VIR)
|
0.1 |
$3.5M |
|
81k |
43.53 |
Stevanato Group SpA Shares
(STVN)
|
0.1 |
$3.5M |
|
138k |
25.31 |
Forma Therapeutics Holdings Shares
|
0.1 |
$3.5M |
|
150k |
23.19 |
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$3.4M |
|
210k |
16.38 |
Steris Shares
(STE)
|
0.1 |
$3.4M |
|
17k |
204.27 |
Arcutis Biotherapeutics Common
(ARQT)
|
0.1 |
$3.1M |
|
132k |
23.89 |
Healthcare Realty Trust Common
|
0.1 |
$3.1M |
|
104k |
29.78 |
West Pharmaceutical Services Common
(WST)
|
0.1 |
$2.6M |
|
6.2k |
424.52 |
Bio-Techne Corp. Common
(TECH)
|
0.1 |
$2.6M |
|
5.4k |
484.63 |
Xenon Pharmaceuticals Common
(XENE)
|
0.1 |
$2.6M |
|
169k |
15.28 |
Global Medical REIT Common
(GMRE)
|
0.1 |
$2.6M |
|
175k |
14.70 |
Stoke Therapeutics Common
(STOK)
|
0.1 |
$2.5M |
|
99k |
25.44 |
Helix Acquisition Corp. Class A Common
|
0.1 |
$2.5M |
|
250k |
9.87 |
Perrigo Company Shares
(PRGO)
|
0.1 |
$2.4M |
|
51k |
47.32 |
Healthcare Trust of America Common
|
0.1 |
$2.1M |
|
71k |
29.66 |
Hologic Common
(HOLX)
|
0.1 |
$2.1M |
|
28k |
73.80 |
TCR2 Therapeutics Common
|
0.1 |
$2.0M |
|
236k |
8.51 |
Morphic Holding Common
(MORF)
|
0.1 |
$2.0M |
|
35k |
56.65 |
Codexis Common
(CDXS)
|
0.1 |
$1.9M |
|
80k |
23.26 |
KalVista Pharmaceuticals Common
(KALV)
|
0.1 |
$1.7M |
|
100k |
17.45 |
TScan Therapeutics Common
(TCRX)
|
0.1 |
$1.7M |
|
200k |
8.34 |
Endo International Shares
|
0.1 |
$1.6M |
|
495k |
3.24 |
Protagonist Therapeutics Common
(PTGX)
|
0.0 |
$1.5M |
|
86k |
17.72 |
Atreca Class A Common
(BCEL)
|
0.0 |
$1.4M |
|
229k |
6.23 |
Praxis Precision Medicines Common
|
0.0 |
$1.4M |
|
75k |
18.49 |
Zogenix Common
|
0.0 |
$1.4M |
|
89k |
15.19 |
ChemoCentryx Common
|
0.0 |
$1.3M |
|
78k |
17.10 |
Fulcrum Therapeutics Common
(FULC)
|
0.0 |
$1.2M |
|
44k |
28.20 |
Diversified Healthcare Trust Common
(DHC)
|
0.0 |
$1.2M |
|
358k |
3.39 |
Community Health Systems Common
(CYH)
|
0.0 |
$1.2M |
|
102k |
11.70 |
iTeos Therapeutics Common
(ITOS)
|
0.0 |
$1.1M |
|
42k |
27.01 |
Black Diamond Therapeutics Common
(BDTX)
|
0.0 |
$1.1M |
|
132k |
8.46 |
MorphoSys Sponsored ADS
(MOR)
|
0.0 |
$963k |
|
82k |
11.76 |
Bolt Biotherapeutics Common
(BOLT)
|
0.0 |
$823k |
|
65k |
12.66 |
Nkarta Common
(NKTX)
|
0.0 |
$806k |
|
29k |
27.80 |
Intercept Pharmaceuticals Common
|
0.0 |
$773k |
|
52k |
14.85 |
Precision BioSciences Common
|
0.0 |
$727k |
|
63k |
11.54 |
Ardelyx Common
(ARDX)
|
0.0 |
$712k |
|
539k |
1.32 |
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$673k |
|
15k |
45.17 |
1Life Healthcare Common
|
0.0 |
$633k |
|
31k |
20.25 |
Universal Health Realty Income Trust Shares
(UHT)
|
0.0 |
$622k |
|
11k |
55.25 |
National Health Investors Common
(NHI)
|
0.0 |
$537k |
|
10k |
53.50 |
ALX Oncology Holdings Common
(ALXO)
|
0.0 |
$524k |
|
7.1k |
73.81 |
Gamida Cell Shares
|
0.0 |
$463k |
|
118k |
3.92 |
Corbus Pharmaceuticals Holdings Common
|
0.0 |
$422k |
|
414k |
1.02 |
Assertio Holdings Common
(ASRT)
|
0.0 |
$372k |
|
411k |
0.91 |
Fusion Pharmaceuticals Common
|
0.0 |
$344k |
|
43k |
7.93 |
Spectrum Pharmaceuticals Common
|
0.0 |
$250k |
|
115k |
2.18 |
VYNE Therapeutics Common
|
0.0 |
$188k |
|
135k |
1.39 |
Organon & Co. Common
(OGN)
|
0.0 |
$122k |
|
3.7k |
32.82 |
Five Star Senior Living Common
|
0.0 |
$106k |
|
24k |
4.37 |
ARCA biopharma Common
(ABIO)
|
0.0 |
$96k |
|
33k |
2.96 |
Bellicum Pharmaceuticals Common
|
0.0 |
$18k |
|
6.0k |
3.00 |